The PHC Group is a global healthcare company group that consists of group companies under the umbrella of PHC Holdings Co., Ltd. such as PHC Corporation and Ascensia Diabetes Care Holdings AG. It develops products and services in diabetes management, diagnostics, life sciences and healthcare services.
*1 As of March 2019 (Excluding Epredia and LSI Medience Corporation)
*2 As of March 2020
Core Business Areas
The PHC Group offers products and services taking advantage of high technology with many major products enjoying significant market shares.
*1 Combined market share of Arkray and Sanwa
*2 Total market share of Ascensia Diabetes Care Holdings AG and other distributors
Note 2: Copyright © 2019 IQVIA., Reprinted with permission.
Note 3: The number of market share in Japan is calculated based on MIDAS 2017Q1-Q4 and estimated by in-house investigation.
Note 4: The number of global market share is based on aggregation of IQVIA MIDAS 2017 Q1-Q4 data and other syndicated sources.
Learn more about our diabetes care
*1 Source: “Latest Trends and Future Potentiality of Tissue Engineering Related Market 2019” by Fuji Keizai Co., Ltd. (based on 2018 performance by volume)
*2 Source: Research by Frost & Sullivan (Base: unit in FY2018)
Learn more about our life sciences products
*1 Source: Survey by Yano Research Institute Ltd. as of August 2019
*2 Source: Survey by Seed Planning 2011
A Foundation Built on Manufacturing and the Strengths of High Technology
The PHC Group leads the healthcare industry with innovative products, created with the foundation in manufacturing and high technology accumulated for over 50 years.
History of PHC Group